Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2013
10/10/2013US20130267456 Therapeutic applications of smad7
10/10/2013US20130267455 Crosslinked peptide hydrogels
10/10/2013US20130267024 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
10/10/2013US20130266663 Sox9 inhibitors
10/10/2013US20130266659 Methods of treating bladder cancer
10/10/2013US20130266648 Tableted compositions containing atazanavir
10/10/2013US20130266614 Lipid carrier for delivery of bioactive substance and pharmaceutical composition
10/10/2013US20130266610 Stimulating anti-tumor immune response and boosting cancer immunotherapy via expression of 15-pgdh
10/10/2013US20130266583 Clostridium difficile antigens
10/10/2013US20130266576 Therapeutic factor viii antibodies
10/10/2013US20130266556 Processing biomass
10/10/2013US20130266555 Therapeutic agent for disc herniation
10/10/2013US20130266553 Albumin Fusion Proteins
10/10/2013US20130266537 Moesin modulators and uses thereof
10/10/2013US20130266536 Method of use of stabilized plant-derived growth factor in skin care
10/10/2013DE102012102998A1 New polymer comprising two substances that bind to amyloid-beta-oligomers, useful for treating Alzheimer's disease, Parkinson's disease, Creutzfeldt Jakob disease or diabetes
10/10/2013CA2834083A1 Methods of treatment with arginine deiminase
10/09/2013EP2647721A1 Peptide with safer secondary structure, peptide library, and production methods for same
10/09/2013EP2647645A1 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
10/09/2013EP2647386A1 Lissencephaly therapeutic agent
10/09/2013EP2647369A1 Use of pacap for treating viral infections in aquatic organisms
10/09/2013EP2646552A1 Muteins of human lipocalin 2 with affinity for ctla-4
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2646473A2 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
10/09/2013EP2646464A1 Anticancer fusion protein
10/09/2013EP2646462A2 Methods and compositions for monitoring phagocytic activity
10/09/2013EP2646059A2 Protease degradable polypeptides and uses thereof
10/09/2013EP2646047A2 Use of prokaryotic sphingosine-1-phosphate lyases and of sphingosine-1-phosphate lyases lacking a transmembrane domain for treating hyperproliferative and other diseases
10/09/2013EP2646046A2 Compositions and methods for the treatment of nervous disorders associated with diabetes
10/09/2013EP2646045A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
10/09/2013EP2646044A1 Methods for increasing intracellular activity of hsp70
10/09/2013EP2646043A1 Novel cyclosporin derivatives for the treatment and prevention of a viral infection
10/09/2013EP2646038A1 New treatments of hepatitis c virus infection
10/09/2013EP2645998A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
10/09/2013EP2645987A1 Novel catalases
10/09/2013EP2471811A9 Oxyntomodulin derivatives
10/09/2013EP2359854B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
10/09/2013EP2261378B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class i membrane fusogenic envelope proteins
10/09/2013CN103347533A Citrate free pharmaceutical compositions comprising anakinra
10/09/2013CN103347532A Orally bioavailable peptide drug compositions and methods thereof
10/09/2013CN103347531A Skin collagen production promoter
10/09/2013CN103347530A Therapeutic agent and preventive agent for diabetes
10/09/2013CN103347521A Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/09/2013CN103347514A FGFR1 extracellular domain combination therapies
10/09/2013CN103347497A Food supplement and injectable material for prophylaxis and therapy of osteoporosis and other bone diseases
10/09/2013CN103343134A EGF-Fc fusion protein and High-expression production method of mammal expression system of EGF-Fc fusion protein
10/09/2013CN103342744A Angiogenesis protein and application thereof
10/09/2013CN103342743A Preparation method and application of recombinant antibacterial peptide Dermadistinctin-Q1
10/09/2013CN103341178A Pyridoxal phosphate functionalized calcium phosphate nano-particles, as well as preparation method and application thereof
10/09/2013CN103341161A Preparation method for sodium alginate-lysozyme compound microcapsule
10/09/2013CN103341160A Pharmaceutical composition containing interferon and application
10/09/2013CN103341159A Application of immune regulation markers TIPE2 (Tumor Necrosis Factor-a Induced Protein 8 like 2) in preparation of medicine used for treating vascular proliferation diseases
10/09/2013CN103341158A Application of beta-arrestin-1 to preparation of drugs for preventing and treating ischemia-induced nerve injury diseases
10/09/2013CN103341157A Application of pingyangmycin combined sodium hyaluronate in medicine for treating venous malformation
10/09/2013CN103341156A Recombinant anti-hypertension peptide enteric-coated nanoparticles as well as preparation method and application thereof
10/09/2013CN103341155A Stable compound coenzyme preparation and preparation method as well as application thereof
10/09/2013CN103341154A Compound veterinary injection for clearing heat and removing toxin
10/09/2013CN103340902A Composition containing cardiogenic factors, associated method, cell, and applications of composition, method and cell
10/09/2013CN103340839A Preparation method of earthworm fibrinolytic modified enzyme chitosan enteric microsphere capsule
10/09/2013CN102702333B Drug-resistant pathogen infection resistant polypeptide and uses thereof
10/09/2013CN102690324B Gynura bicolor protein extract, and preparation method and application thereof
10/09/2013CN102421796B Novel exendin variant and conjugate thereof
10/09/2013CN102304540B Expression equipment for expressing exogenous protein by secretion in trichoderma reesei and application of expression equipment
10/09/2013CN102198264B Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof
10/08/2013US8554804 System and method for monitoring and analyzing internet traffic
10/08/2013US8552171 RNA sequence-specific mediators of RNA interference
10/08/2013US8552159 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/08/2013US8552158 Method for the production of insulin-like growth factor-1
10/08/2013US8552152 Compositions and methods for modulating dopamine neurotransmission
10/08/2013US8552149 Polypeptides and use thereof
10/08/2013US8552148 TNF-α antagonists containing IGFBP5
10/08/2013US8552147 Peptides and compositions for prevention of cell adhesion and methods of using same
10/08/2013US8552016 Anti-cancer cyclopenta(g)quinazoline compounds
10/08/2013US8551998 Delta opioid receptor agonist compounds
10/08/2013US8551970 Genetic suppression and replacement
10/08/2013US8551956 Compositions containing peptides with non-natural amino acids and methods of use
10/08/2013US8551955 Dimeric Smac mimetics
10/08/2013US8551954 Antimicrobial peptides with heparin binding activity
10/08/2013US8551953 Treatment of T-cell mediated diseases
10/08/2013US8551952 Methods for the treatment and prevention of ocular disorders
10/08/2013US8551951 Pharmaceutical preparations and methods for inhibiting tumors
10/08/2013US8551950 Method of treatment or prophylaxis of inflammatory pain
10/08/2013US8551949 Methods for treatment of pain
10/08/2013US8551948 Albumin fibers and fabrics and methods of generating and using same
10/08/2013US8551947 Treatment of hibernating myocardium with an exendin peptide
10/08/2013US8551946 Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
10/08/2013US8551945 Methods and compositions for treating neuropathies
10/08/2013US8551942 Lyophilized anti-fungal compositions
10/08/2013US8551941 Process of making flowable hemostatic compositions and devices containing such compositions
10/08/2013US8551940 Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
10/08/2013US8551939 Peptide analogues, particularly for the treatment of chronic pain
10/08/2013US8551938 NPR-B agonists
10/08/2013US8551937 Peptide having an extending action for half-life of object peptide in plasma
10/08/2013US8551936 Defensin-antigen fusion proteins
10/08/2013US8551916 Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent
10/08/2013US8551790 MASP 2, a complement-fixing enzyme, and uses for it
10/08/2013US8551757 Bacillus thuringiensis isolate
10/08/2013US8551721 Bioluminescent detection of cyanohydroxy benzothiazole compounds
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551528 Diketopiperazine microparticles with defined specific surface areas
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 3163